BNGO

Bionano Genomics Inc. Common Stock (BNGO)

Stock · NASDAQ · Industrials

$1.25as of 10/16/2026

Active signals

Support level
$1.12
Industry
Biotechnology: Laboratory Analytical Instruments

What BNGO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike31-12.3%26%
Bollinger Band Breakdown24-6.9%29%
Bollinger Band Breakout19-13.7%26%
200-Day Moving Average TouchActive now5-22.1%20%
Any 20-session window (baseline)-8.6%31%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BNGO

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal…

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Employees
95

Fundamentals

1-day range
$1.25$1.39
Market cap
$12.62M
P/E (trailing)
—
P/E (forward)
-1.29
EPS (trailing)
$-3.76
Dividend yield
—
Beta
1.72
Avg. volume
932.3K
52-week range
$1$2.23
Next earnings: November 12, 2026 · EPS estimate $-0.54confirmed

How Bionano Genomics Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$28.51MSG&A$35.15M (123%)Cost of Revenue$15.32M (54%)R&D$11.37M (40%)Tax$67.0K (0%)BNGO

Source: 10-K filed Mar 23, 2026 · via SEC EDGAR / Finnhub

Gross Profit$13.19M(46%)
Operating Income-$33.34M(-117%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$6
+380.0%
Median
$5
+300.0%
Low
$4
+220.0%

Bionano Genomics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • BNGO
    Bionano Genomics Inc. Common Stock
    $1.25
    ▼ 8.76%
    Market cap $12.62MP/E —
    $1$2.23
  • ASTC
    Astrotech Corporation (DE) Common Stock
    $4.93
    ▼ 5.19%
    Market cap $18.10MP/E —
    $1.92$68.85
  • HBIO
    Harvard Bioscience Inc. Common Stock
    $8.09
    ▼ 2.65%
    Market cap $27.92MP/E —
    $3.75$9.4
  • PRPO
    Precipio Inc. Common Stock
    $21.38
    ▼ 5.17%
    Market cap $41.93MP/E —
    $16.4$33.63
  • CIRC
    Circle8 Group Inc. Common Stock
    $0.302
    ▼ 5.33%
    Market cap $70.73MP/E —
    $0.3132$0.98
  • RPID
    Rapid Micro Biosystems Inc. Class A Common Stock
    $0.764
    ▼ 9.59%
    Market cap $96.03MP/E —
    $0.8087$4.94
  • NAUT
    Nautilus Biotechnology Inc. Common Stock
    $2.06
    ▼ 4.63%
    Market cap $112.76MP/E —
    $0.8399$4.31

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
142.7K
Disposed
82

Institutional Ownership

March 31, 2026

Total shares held
818.9K
Total value held
$529.0K
Institutional holders
28
Top holders this quarter
  • Unknown353.4K
  • Unknown167.5K
  • Unknown70.0K
  • Unknown68.1K
  • Unknown48.7K
  • Unknown28.0K
  • Unknown20.5K
  • Unknown18.1K
  • Unknown13.8K
  • Unknown11.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.